Cystathionine beta-synthase is coordinately regulated with proliferation through a redox-sensitive mechanism in cultured human cells and Saccharomyces cerevisiae.
Cystathionine beta-synthase (CBS) catalyzes the condensation of serine with homocysteine to form cystathionine and occupies a crucial regulatory position between the methionine cycle and the biosynthesis of cysteine by transsulfuration. Analysis of CBS activity under a variety of growth conditions indicated that CBS is coordinately regulated with proliferation in both yeast and human cells. In batch cultures of Saccharomyces cerevisiae, maximal CBS activities were observed in the exponential phase of cells grown on glucose, while growth-arrested cultures or those growing non-fermentatively on ethanol or glycerol had approximately 3-fold less activity. CBS activity assays and Western blotting indicated that growth-specific regulation of CBS is evolutionarily conserved in a range of human cell lines. CBS activity was found to be maximal during proliferation and was reduced two- to five-fold when cells became quiescent at confluence. In cultured HepG2 cells, the human CBS gene is induced by serum and basic fibroblast growth factor and is downregulated, but not abolished, by contact inhibition, serum-starvation, nutrient depletion, or the induction of differentiation. Consequently, for certain cell types, CBS may represent a novel marker of both differentiation and proliferation. The intracellular level of the CBS regulator compound, S-adenosylmethionine, was found to reflect the proliferation status of both yeast and human cells, and as such, constitutes an additional mechanism for proliferation-specific regulation of human CBS. Our data indicates that screening compounds for the ability to affect transsulfuration in cultured cell models must take proliferation status into account to avoid masking regulatory interactions that may be of significance in vivo.
Department of Pediatrics, University of Colorado School of Medicine, Denver, Colorado 80262, USA.
Kenneth N
KN
Maclean
Miroslav
M
Janosík
Eva
E
Kraus
Viktor
V
Kozich
Robert H
RH
Allen
Beverly K
BK
Raab
Jan P
JP
Kraus
D001790:Blood Physiological Phenomena; D002454:Cell Differentiation / Q000502:physiology; D002455:Cell Division / Q000502:physiology; D002477:Cells / Q000166:cytology* / Q000201:enzymology*; D003541:Cystathionine beta-Synthase / Q000235:genetics / Q000378:metabolism*; D015536:Down-Regulation; D016222:Fibroblast Growth Factor 2 / Q000494:pharmacology; D005786:Gene Expression Regulation; D006801:Humans; D007527:Isoenzymes / Q000235:genetics; D010084:Oxidation-Reduction; D011401:Promoter Regions, Genetic / Q000187:drug effects / Q000502:physiology; D012436:S-Adenosylmethionine / Q000378:metabolism; D012441:Saccharomyces cerevisiae / Q000201:enzymology* / Q000254:growth & development*; D014407:Tumor Cells, Cultured
D007527:Isoenzymes; D016222:Fibroblast Growth Factor 2; D012436:S-Adenosylmethionine; D003541:Cystathionine beta-Synthase